Wolfgang Miesbach: iTTP Remission ≠ Cure. The Vascular Injury Persists
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
“iTTP remission ≠ cure. The vascular injury persists. TTP as a cardiovascular disease equivalent. Just finished Dr. Senthil Sukumar‘s ASH25 session on long-term iTTP management. This completely changed how I think about these patients.

The Numbers Hit Different:
- 28.6% of survivors → major cardiovascular events
- 50% → silent cerebral infarcts (vs 16.6% controls)
- Cardiovascular complications 10–20 years EARLIER
- 80% depression | 35% post traumatic stress disorder
- >60% measurable neurocognitive impairment
- 71% moderate-severe headaches
- 20% can’t work due to complications
The Game Changer: Endothelial Damage That Doesn’t Heal
Patients are not ‘fine’ after remission. The endothelium stays injured. Stress cardiac MRI shows reduced perfusion + impaired coronary vasodilation—the heart can’t increase blood flow under stress even when ADAMTS13 normalizes.
The Actionable Part 💡
ADAMTS13 ≤70% = 27.6% stroke rate
ADAMTS13 >70% = ZERO ischemic strokes
As a consequence, treat iTTP as CVD Equivalent
- Comprehensive cardiovascular risk factor optimization (lipids, A1C, smoking, BP, weight, activity)
- Baseline mood + neurocognitive screening for ALL survivors
- Neuropsych testing every 1–2 years
- Multidisciplinary teams (neuro, psych, cardio)”
Get the latest from Hemostasis Today.
-
Mar 17, 2026, 15:55Mostafa Faisal Mohammed Saleh: Evidence-Based Recommendations for Hodgkin Lymphoma Management in LMICs
-
Mar 17, 2026, 15:50Yogesh Kalkonde: Advancing Sickle Cell Care Through Primary Health Training
-
Mar 17, 2026, 15:49Melissa Hollo: Closing the Gap in Maternal Anemia Care Through HerCare
-
Mar 17, 2026, 15:46Simon Senanu: Rouleaux Formation – When Red Cells Stack Like Coins
-
Mar 17, 2026, 15:45Heghine Khachatryan: Hidden Hematologic Causes of Cryptogenic Stroke
-
Mar 17, 2026, 15:45Wolfgang Miesbach: Six Years of Normal Factor VIII After a Single Gene Therapy in Hemophilia A
-
Mar 17, 2026, 15:44Jan Sloves: Venous Phasicity and the Role of IVC Mechanics
-
Mar 17, 2026, 15:43How Clinicians Navigate the Challenge of Balancing Clotting and Bleeding in CAD – Vasculearn Network
-
Mar 17, 2026, 15:41Beverly G. Tchang: Lipid-Lowering Therapy in Women During Pregnancy and Lactation